Walgreens Globals

RYBELSUS® (semaglutide) tablets 3mg, 7 mg or 14 mg is a prescription medicine used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes.

• It is not known if RYBELSUS® can be used in people who have had pancreatitis
• RYBELSUS® is not for use in people with type 1 diabetes
• It is not known if RYBELSUS® is safe and effective for use in children under 18 years of age

• Key takeaways:

  • Rybelsus (semaglutide) is an oral medication approved to treat Type 2 diabetes. It contains the same active ingredient as Ozempic and Wegovy. Ozempic is approved for Type 2 diabetes, and Wegovy is approved for chronic weight management.

  • Rybelsus is currently being studied for weight loss in clinical trials. These studies involve higher doses than what’s currently approved and available for diabetes. 

  • Results show that an oral semaglutide (Rybelsus) dose of 50 mg results in similar weight loss as Wegovy. Due to these findings, Rybelsus’ manufacturer plans to request FDA approval in 2023. If approved for weight loss, it may be marketed under a different brand name.

Lobg Tablet may be used alone or along with other medicines. It may be taken with or without food. However, take it regularly at the same time each day to get the most benefits. Your doctor will decide what dose is best for you and this may change from time to time according to this drug’s effect on you.

Keep taking Lobg Tablet, even if you feel well or your blood sugar levels are controlled. If you stop it without consulting the doctor, your blood sugar levels could rise and put you at risk of kidney damage, blindness, nerve problems, and loss of limbs. Remember that it is only a part of the treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by the doctor. Your lifestyle plays a big part in controlling diabetes.

The most common side effects of taking this medicine include edema, fatigue, and weight gain. Please consult your doctor if these bother you or persist for a longer duration.

You should not take it if you have type 1 diabetes mellitus, diabetic ketoacidosis (high levels of acid in your blood), or severe kidney or liver disease. Before taking this medicine, tell your doctor if you have ever had heart disease, thyroid disease, or some hormonal conditions.
Pregnant or breastfeeding women should also consult their doctor before taking it. Get your blood sugar levels checked regularly, and your doctor may also advise blood tests to monitor your blood cell counts and liver function.

Product Name: Kilfat Tablet

Brand Name: Kilfat, Cetislim, Checkmate

Composition: Cetilistat (60mg)

Manufacturer/Marketer: Akumentis Healthcare Ltd

Packaging: To be provided (specify packaging details if available)

Treatment: Obesity management (weight loss medication)

Product Description: Kilfat Tablet contains Cetilistat, a lipase inhibitor used for managing obesity. It works by blocking the absorption of dietary fats in the intestines, aiding in weight reduction. It is usually prescribed as part of a comprehensive weight loss program, including a healthy diet and exercise